Previous close | 4.6400 |
Open | 4.6500 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 4.5500 - 4.6800 |
52-week range | 4.4400 - 6.6400 |
Volume | |
Avg. volume | 51,489 |
Market cap | 3.468B |
Beta (5Y monthly) | 0.27 |
PE ratio (TTM) | 35.94 |
EPS (TTM) | 0.1280 |
Earnings date | N/A |
Forward dividend & yield | 0.05 (1.14%) |
Ex-dividend date | 18 Mar 2022 |
1y target est | N/A |
On 3 May 2022 the decision was made to grant to employees 175,000 shares through stock option agreements, thereof 84,100 to the Executive Team. The stock options are granted to a member of the Executive Team and selected employees in strategic positions, in total 4 employees, the granting is in relation to new hires and changes in strategic positions. The aim of the stock option agreements is to align long-term interests of employees and of the Company. The key terms and conditions of the option
Marel announced the agreement to acquire a global leader in processing solutions focused on pet food, plant-based proteins, and aqua feed, on Wednesday 27 April 2022. Please find attached the investor presentation for today’s additional investor meeting at 2pm GMT (4pm CET/3pm BST/9amCDT/10am EDT), where senior management will give an overview of the acquisition, business strategy and growth objectives. The virtual meeting is webcast live and a recording is available after the meeting on marel.c
Marel hf. published its Q1 2022 Condensed Consolidated Financial Interim Statements after market closing on 27 April 2022. Please find attached the Q1 2022 investor presentation for today’s virtual investor meeting at 8:30 am GMT (10:30 am CET), where senior management will give an overview of the financial results and operational highlights in the first quarter. The meeting is webcast live on marel.com/webcast and a recording is available after the meeting on marel.com/ir. Members of the invest